Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Up 201.5% in January

Aethlon Medical, Inc. (NASDAQ:AEMD) saw a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 1,190,000 shares, a growth of 201.5% from the December 31st total of 394,700 shares. Based on an average daily volume of 3,000,000 shares, the days-to-cover ratio is currently 0.4 days.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on AEMD shares. HC Wainwright restated a “buy” rating and set a $7.00 price target on shares of Aethlon Medical in a report on Thursday. StockNews.com assumed coverage on Aethlon Medical in a research report on Monday. They issued a “sell” rating for the company.

Aethlon Medical Trading Down 1.5 %

Shares of NASDAQ:AEMD opened at $0.73 on Friday. The business has a 50-day moving average price of $0.56 and a 200 day moving average price of $0.45. Aethlon Medical has a 12-month low of $0.24 and a 12-month high of $1.88. The company has a market capitalization of $10.19 million, a price-to-earnings ratio of -0.26 and a beta of 1.61.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.